← Retour au Screener

Sector: Matériaux de Base
Open in Terminal → NGVTLive chart · Key metrics · News · Smart money

Ingevity Corporation

NGVT Mid Cap

Basic Materials · Specialty Chemicals

Mis à jour: Jun 18, 2026, 22:21 UTC

64,00 €
+2.31% aujourd'hui
52W: 34,64 € – 69,12 €
52W Low: 34,64 € Position: 85.1% 52W High: 69,12 €

Price Chart

Indicateurs clés

P/E Ratio
Cours/Bénéfice
Forward P/E
12.76x
P/E prévisionnel
P/S Ratio
2.17x
Cours/Ventes
EV/EBITDA
10.11x
Valeur d'entreprise/EBITDA
Rend. dividende
Rendement annuel du dividende
Cap. boursière
2,2 Md €
Capitalisation boursière
Croissance du CA
4.1%
Croissance du CA sur un an
Marge bénéficiaire
-10.85%
Marge nette
ROE
-114.08%
Rentabilité des capitaux propres
Beta
1.19
Sensibilité au marché
Positions vendeuses
3.81%
% du flottant vendu à découvert
Volume moyen
255,009
Volume quotidien moyen

Valuation Analysis

Signal
N/A
vs. S&P 500 avg P/E (24.7x)
Analyst Consensus
None
4 analysts
Avg. Price Target
74,54 €
+16.47% upside
Target Range
65,38 € – 80,20 €

About the Company

Sector: Basic Materials Industry: Specialty Chemicals Country: United States Employees: 1,400 Exchange: NYQ

Ingevity Corporation en bref

Ingevity Corporation (NGVT) is currently trading at 64,00 € with a market capitalization of 2,2 Md €. The 52-week range spans from 34,64 € to 69,12 €; the current price is 7.4% below the yearly high. Year-over-year revenue growth stands at +4.1%.

💰 Dividende

Ingevity Corporation currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

4 analystes évaluent Ingevity Corporation (NGVT) au consensus : None. L'objectif de cours moyen est de 74,54 €, soit un potentiel de +16.47% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 65,38 € à 80,20 €.

Ingevity Corporation : la thèse d'investissement en détail

Ingevity Corporation (NGVT) operates in the Basic Materials — specifically Specialty Chemicals — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Earnings growth of 199% is outpacing revenue, a sign of operational leverage — fixed costs are being absorbed across a larger base.

Le scénario baissier

Revenue growth has slowed to just 4.1%, which is below nominal GDP — the business is no longer outgrowing the broader economy. Net margins remain negative, meaning every euro of revenue is still producing losses — the path to profitability is the central question for shareholders. The debt-to-equity ratio of 3200% is elevated, meaning the company relies heavily on creditors — refinancing terms will become more important than operational performance in the next economic downturn.

Thèse d'investissement : forces et faiblesses

Points forts
  • Free cash flow positif
Points faibles
  • Actuellement non rentable
  • Endettement élevé (D/E 3200)

Aperçu technique

MM 50 jours
62,51 €
+2.38% vs. cours
MM 200 jours
55,43 €
+15.46% vs. cours
Sous le plus haut 52s
−7.4%
69,12 €
Au-dessus du plus bas 52s
+84.7%
34,64 €

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Profil de risque

Risque de marché (Bêta)
1.19 · Proche du marché
Évolue plus que le marché global
Positions vendeuses
3.81% · Faible
% du flottant vendu à découvert
Dette/Capitaux propres
3200 · Élevé
Dette totale / capitaux propres

The data points to market-like volatility, higher leverage relative to equity.

Trading Data

50-Day MA: 62,51 €
200-Day MA: 55,43 €
Volume: 632,196
Avg. Volume: 255,009
Short Ratio: 3.69
P/B Ratio: 65.84x
Debt/Equity: 3200x
Free Cash Flow: 197 M €

More Matériaux de Base stocks

Top peers in the same sector — ranked by market cap.

View full Matériaux de Base sector page →

Where can I buy Ingevity Corporation?

Compare top-rated brokers — low fees, trusted providers, fully regulated.

Live Market Data

Real-time chart, financials, earnings, analysts, insider trades, events & news

Financials

Earnings

Analyst Ratings

Insider Trades

Events Timeline

News + Sentiment

Peer Comparison

Retour en haut